Oculus Pentacam AXL , Ref 70100, CE 0123
FDA Device Recall #Z-2483-2023 — Class II — August 8, 2023
Recall Summary
| Recall Number | Z-2483-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 8, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Oculus Optikgeraete GMBH |
| Location | Wetzlar, N/A |
| Product Type | Devices |
| Quantity | 364 units |
Product Description
Oculus Pentacam AXL , Ref 70100, CE 0123
Reason for Recall
Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.
Distribution Pattern
US Nationwide distribution in the states of CA, FL, MA, MN, NY, NC, OH, PA, TX, VA, WA. OUS: Not Provided
Lot / Code Information
UDI-DI; (01) 04049584012333
Other Recalls from Oculus Optikgeraete GMBH
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2484-2023 | Class II | Oculus Myopia Master , Ref 68100, CE 0123 | Aug 8, 2023 |
| Z-2482-2023 | Class II | Oculus Pentacam AXL Wave, Ref 70020, CE 0123 | Aug 8, 2023 |
| Z-1673-2022 | Class II | Pentacam AXL REF 70100, Pentacam HR REF 7090... | Jul 8, 2022 |
| Z-1672-2022 | Class II | Pentacam AXL Wave REF 70020. Used to image the... | Jul 8, 2022 |
| Z-1674-2022 | Class II | Pentacam HR REF 70900. Used to image the anter... | Jul 8, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.